William A. Curran
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/27077_wcurran_0.jpg?itok=AAa9MU_H)
Filters
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
Elliott Investment Management acquires majority interest in American Greetings
We are advising Elliott on the transaction
MoneyLion $1 billion acquisition by Gen Digital
We are advising MoneyLion on the acquisition
Citi acquisition of Barclays American Airlines co-branded card portfolio
We are advising Citi on the acquisition
Cross Country Healthcare $615 million acquisition by Aya Healthcare
We are advising Cross Country Healthcare on the transaction
Summit Materials $11.5 billion acquisition by Quikrete Holdings
We are advising Summit Materials on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Marsh McLennan $7.25 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Silver Spike Investment Corp. loan portfolio acquisition
We advised Silver Spike Investment Corp., now named Chicago Atlantic BDC, Inc., on the transaction